BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Atenolol

A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.

297+ PubMed studies analyzed · 98 RCTs · Evidence Score: 57

Research Domains

Atenolol has been studied across 17 research domains including ❤️ Cardiovascular, 🔥 Metabolic, 🫘 Kidney, 😴 Sleep, 🧠 Focus & Attention. The primary research focus is ❤️ Cardiovascular with 53% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Atenolol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Acebutolol
5 shared targets
Phenylephrine
7 shared targets
Carteolol
4 shared targets
Celiprolol
4 shared targets
Oxprenolol
4 shared targets
bmy
4 shared targets
nan
4 shared targets
Timolol
5 shared targets
levisoprenaline
3 shared targets
l
3 shared targets
Loading evidence profile...

This evidence profile for Atenolol is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.